These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 24878900)

  • 1. [Antimicrobial susceptibility in Chile 2012].
    Cifuentes-D M; Silva F; García P; Bello H; Briceño I; Calvo-A M; Labarca J;
    Rev Chilena Infectol; 2014 Apr; 31(2):123-30. PubMed ID: 24878900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Results of antimicrobial susceptibility surveillance in Chile: consolidating a network].
    Silva O F; Cifuentes D M; Pinto C ME
    Rev Chilena Infectol; 2011 Feb; 28(1):19-27. PubMed ID: 21526281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In vitro susceptibility patterns of bacterial species isolated in outpatients of the Metropolitan Región, Chile, year 2007].
    Camponovo C R
    Rev Chilena Infectol; 2009 Feb; 26(1):18-20. PubMed ID: 19350154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Recommendations for the analysis of cumulated data in antimicrobial susceptibility in health institutions].
    Comité de Microbiología, Sociedad Chilena de Infectología
    Rev Chilena Infectol; 2010 Apr; 27(2):126-32. PubMed ID: 20556314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiological surveillance of the resistance to antimicrobial agents in pathogenic or potentially pathogenic germs of medical interest.
    Dorobăţ O; Rusu V; Paicu L; Niţu R; Caplan D; Făgăraş R; Romanoff E; Pavel A
    Arch Roum Pathol Exp Microbiol; 1988; 47(3-4):163-203. PubMed ID: 3252768
    [No Abstract]   [Full Text] [Related]  

  • 6. [Evolution of use of antibiotics of restricted prescription and trend of bacterial susceptibility in Concepcion Regional Hospital, Chile].
    Morales FE; Villa LA; Fernández PB; López MA; Mella S; Muñoz M
    Rev Chilena Infectol; 2012 Oct; 29(5):492-8. PubMed ID: 23282489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bacteremia in cancer patients. Experience in a pediatric hospital].
    Cortez D; Rodríguez N; Benadof D; Zamorano A; Tordecilla J
    Rev Chilena Infectol; 2012 Apr; 29(2):164-8. PubMed ID: 22689031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Grupo Colaborativo de Resistencia Bacteriana, Chile: recommendations 2014 towards the control of bacteria resistance].
    Cifuentes M; Silva F; Arancibia JM; Rosales R; Ajenjo MC; Riedel G; Camponovo R; Labarca J;
    Rev Chilena Infectol; 2015 Jun; 32(3):305-18. PubMed ID: 26230437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [sensitivity of bacteria to chemotherapeutic agents (Zurich, 1993)].
    Wüst J; Kayser FH
    Praxis (Bern 1994); 1995 Jan; 84(4):98-105. PubMed ID: 7846439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Profile of antimicrobial resistance of agents causing urinary tract infections in Chilean children. PRONARES surveillance program].
    Prado V; Trucco O; Durán C; Mamani R; Royer M;
    Rev Med Chil; 2001 Aug; 129(8):877-85. PubMed ID: 11680961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of pathogen occurrences and resistance profiles among infected patients in the intensive care unit: report from the SENTRY Antimicrobial Surveillance Program (North America, 2001).
    Streit JM; Jones RN; Sader HS; Fritsche TR
    Int J Antimicrob Agents; 2004 Aug; 24(2):111-8. PubMed ID: 15288308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacteraemia in Europe--antimicrobial susceptibility data from the MYSTIC surveillance programme.
    Unal S; Masterton R; Goossens H
    Int J Antimicrob Agents; 2004 Feb; 23(2):155-63. PubMed ID: 15013041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bloodstream infections in children with cancer and high risk fever and neutropenia episodes in six hospitals of Santiago, Chile between 2004 and 2009].
    Solís Y; Álvarez AM; Fuentes D; de la Barra D; Avilés CL; Becker A; Salgado C; Silva P; Topelberg S; Tordecilla J; Varas M; Villarroel M; Viviani T; Zubieta M; Aedo S; Santolaya ME
    Rev Chilena Infectol; 2012 Apr; 29(2):156-62. PubMed ID: 22689029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changing trends in antimicrobial resistance of major bacterial pathogens, 1985-2005: a study from a medical center in northern Taiwan.
    Lo WT; Lin WJ; Chiueh TS; Lee SY; Wang CC; Lu JJ
    J Microbiol Immunol Infect; 2011 Apr; 44(2):131-8. PubMed ID: 21439516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative antimicrobial susceptibility of aerobic and facultative bacteria from community-acquired bacteremia to ertapenem in Taiwan.
    Lee SC; Huang SS; Lee CW; Fung CP; Lee N; Shieh WB; Siu LK
    BMC Infect Dis; 2007 Jul; 7():79. PubMed ID: 17640342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative in vitro susceptibilities of 396 unusual anaerobic strains to tigecycline and eight other antimicrobial agents.
    Goldstein EJ; Citron DM; Merriam CV; Warren YA; Tyrrell KL; Fernandez HT
    Antimicrob Agents Chemother; 2006 Oct; 50(10):3507-13. PubMed ID: 16940056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility testing of bacteria and fungi. Report from "the Norwegian Working Group on Antibiotics".
    Bergan T; Bruun JN; Digranes A; Lingaas E; Melby KK; Sander J
    Scand J Infect Dis Suppl; 1997; 103():1-36. PubMed ID: 9253777
    [No Abstract]   [Full Text] [Related]  

  • 18. Passive surveillance of antimicrobial resistance in Queensland public hospitals: the basis for a national system?
    Nimmo GR; Fong J
    Commun Dis Intell Q Rep; 2004; 28(2):230-5. PubMed ID: 15460960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trending 7 years of in vitro activity of tigecycline and comparators against Gram-positive and Gram-negative pathogens from the Asia-Pacific region: Tigecycline Evaluation Surveillance Trial (TEST) 2004-2010.
    Hawser SP; Bouchillon SK; Hackel M; Chen M; Kim EC
    Int J Antimicrob Agents; 2012 Jun; 39(6):490-5. PubMed ID: 22534507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological properties of the Chilean native moss Sphagnum magellanicum.
    Montenegro G; Portaluppi MC; Salas FA; Díaz MF
    Biol Res; 2009; 42(2):233-7. PubMed ID: 19746269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.